A Phase Ib/II Trial To Test The Safety And Efficacy Of Vaccination With HPV16-E711-19 Nanomer For The Treatment Of Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer In HLA-A*02 Positive Patients

Trial Profile

A Phase Ib/II Trial To Test The Safety And Efficacy Of Vaccination With HPV16-E711-19 Nanomer For The Treatment Of Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer In HLA-A*02 Positive Patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 May 2017

At a glance

  • Drugs DPX E7 (Primary) ; Cyclophosphamide
  • Indications Human papillomavirus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Apr 2017 According to an Immunovaccine media release, first study participant has been treated in this study.
    • 13 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 14 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top